Seeking Alpha

Momenta Pharmaceuticals (MNTA) gains 5.7% AH after announcing it has entered into a...

Momenta Pharmaceuticals (MNTA) gains 5.7% AH after announcing it has entered into a collaboration with Baxter (BAX) to develop a class of drugs called biosimilars. As part of the deal, Baxter will make a $33M up-front payment to Momenta related to the development of six drug compounds, and "may make additional payments over the next several years."
Comments (1)
  • Morochito
    , contributor
    Comment (1) | Send Message
     
    I have owned MNTA for a couple of years now, and use it mostly to sell Call Options against it which have served me well. What do you do?
    28 Dec 2011, 10:02 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector